Recent News

• 06.02.2025 - Protara Therapeutics Announces Appointment of William Conkling as Chief Commercial Officer
• 06.02.2025 - Protara Therapeutics Announces Appointment of William Conkling as Chief Commercial Officer
• 06.02.2025 - Protara Therapeutics Announces Appointment of William Conkling as Chief Commercial Officer
• 05.27.2025 - TD Cowen
• 05.27.2025 - TD Cowen
• 05.22.2025 - Soumit Roy
• 05.22.2025 - Soumit Roy
• 05.20.2025 - H.C. Wainwright 3rd Annual BioConnect Investor Conference at NASDAQ
• 05.20.2025 - H.C. Wainwright 3rd Annual BioConnect Investor Conference at NASDAQ
• 05.13.2025 - Protara Therapeutics to Participate in Upcoming Investor Conferences

Recent Filings

• 05.19.2025 - 4/A Statement of changes in beneficial ownership of securities
• 05.16.2025 - 4 Statement of changes in beneficial ownership of securities
• 05.14.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 05.12.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 05.08.2025 - 8-K Current report
• 05.08.2025 - 10-Q Quarterly report [Sections 13 or 15(d)]